DeepMed Research

Abramson Cancer Center

🇺🇸United States

Country: 🇺🇸United States

Ownership: Subsidiary

Employees: -

Market Cap: -

Website: http://www.pennmedicine.org

Clinical Trials

XmAb20717 in Advanced Biliary Tract Cancers

Phase 2

Active, not recruiting

Conditions: Biliary Tract Cancer

Interventions: Drug: XmAb20717

First Posted Date: 2022-03-28

Last Posted Date: 2024-12-18

Lead Sponsor: Abramson Cancer Center at Penn Medicine

Target Recruit Count: 27

Registration Number: NCT05297903

Locations: 🇺🇸
Abramson Cancer Center at University of Pennsylvania, Philadelphia, Pennsylvania, United States

Zr89 + PET Companion Trial

Early Phase 1

Conditions: Melanoma (Skin)

Interventions: Drug: Zirconium Zr 89 Crefmirlimab Berdoxa

First Posted Date: 2022-03-15

Last Posted Date: 2025-03-05

Lead Sponsor: Abramson Cancer Center at Penn Medicine

Target Recruit Count: 20

Registration Number: NCT05279027

Locations: 🇺🇸
Perleman Center for Advanced Medicine, Philadelphia, Pennsylvania, United States

FTT PET/CT in Metastatic Prostate Cancer

Recruiting

Conditions: Prostate Cancer Metastatic

Interventions: Drug: [18F]FluorThanatrace

First Posted Date: 2022-02-16

Last Posted Date: 2025-02-07

Lead Sponsor: Abramson Cancer Center at Penn Medicine

Target Recruit Count: 30

Registration Number: NCT05242744

Locations: 🇺🇸
University of Pennsylvania Hospital, Philadelphia, Pennsylvania, United States

The Association Between CBT-I Dose, Sleep Duration, and Fatigue in Breast Cancer Patients

Not Applicable

Active, not recruiting

Conditions: Cancer-Related Syndrome
Chronic Insomnia
Cancer-related Problem/Condition

Interventions: Behavioral: Cognitive Behavioral Therapy for Insomnia

First Posted Date: 2022-02-07

Last Posted Date: 2025-05-20

Lead Sponsor: Abramson Cancer Center at Penn Medicine

Target Recruit Count: 64

Registration Number: NCT05226078

Locations: 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States

Comparing Two Ways to Manage Head and Neck Lymphedema

Not Applicable

Recruiting

Conditions: Lymphedema
Head and Neck Cancer

Interventions: Other: Clinic-based CDT
Other: Home-based (a hybrid model) CDT

First Posted Date: 2022-01-10

Last Posted Date: 2025-04-30

Lead Sponsor: Abramson Cancer Center at Penn Medicine

Target Recruit Count: 300

Registration Number: NCT05182229

Locations: 🇺🇸
Jefferson Cherry Hospital Jefferson Health, Cherry Hill, New Jersey, United States
🇺🇸
Jefferson Torresdale Hospital Jefferson Health, Philadelphia, Pennsylvania, United States
🇺🇸
Asplundh Cancer Pavilion Jefferson Health, Willow Grove, Pennsylvania, United States

and more 3 locations

RCT of Strategies to Augment Physical Activity in Black and Hispanic Breast and Prostate Cancer Survivors (ALLSTAR)

Not Applicable

Completed

Conditions: Cardiovascular Diseases
Breast Cancer
Physical Inactivity
Prostate Cancer

Interventions: Behavioral: Attention control
Behavioral: Gamification and Social Support

First Posted Date: 2022-01-04

Last Posted Date: 2025-02-24

Lead Sponsor: Abramson Cancer Center at Penn Medicine

Target Recruit Count: 150

Registration Number: NCT05176756

Locations: 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States
🇺🇸
City of Hope National Medical Center, Duarte, California, United States

Acute Effects of Cigarette Packaging and Charcoal Filtration on Perceptions, Use Behaviors, and Harm Exposure

Not Applicable

Completed

Conditions: Smoking Behaviors

Interventions: Other: Cigarette A
Other: Cigarette B

First Posted Date: 2021-12-14

Last Posted Date: 2024-11-07

Lead Sponsor: Abramson Cancer Center at Penn Medicine

Target Recruit Count: 42

Registration Number: NCT05157048

Locations: 🇺🇸
Center for Interdisciplinary Research on Nicotine Addiction, University of Pennsylvania, Philadelphia, Pennsylvania, United States

Text-based Intervention to Minimize the Time Burden of Routine Cancer Care

Not Applicable

Completed

Conditions: Solid Tumor
Patient Empowerment
Cancer
Telemedicine

Interventions: Other: Text triage

First Posted Date: 2021-11-26

Last Posted Date: 2025-03-06

Lead Sponsor: Abramson Cancer Center at Penn Medicine

Target Recruit Count: 40

Registration Number: NCT05134636

Locations: 🇺🇸
Perelman Center for Advanced Care, Philadelphia, Pennsylvania, United States

CTNNA1 Familial Expansion Study

Recruiting

Conditions: Cancer Gene Mutation
Breast Cancer
Gastric Cancer

First Posted Date: 2021-11-19

Last Posted Date: 2025-03-06

Lead Sponsor: Abramson Cancer Center at Penn Medicine

Target Recruit Count: 100

Registration Number: NCT05126290

Locations: 🇺🇸
Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania, United States

'Penny', a SMS Text-based Chatbot Intervention for Medication Adherence and Side Effect Management Among Patients With GI Cancers

Not Applicable

Completed

Conditions: Gastrointestinal Cancer

Interventions: Device: 'Penny' via Memora Platform

First Posted Date: 2021-11-09

Last Posted Date: 2024-12-17

Lead Sponsor: Abramson Cancer Center at Penn Medicine

Target Recruit Count: 60

Registration Number: NCT05113264

Locations: 🇺🇸
Abramson Cancer Center, Philadelphia, Pennsylvania, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy